Plan the two-month washout before you try
Semaglutide stays in your body for a long time after an injection. The two-month gap is a precaution before you try to conceive. Skipping a dose on the day of a positive test does not meet the advice. Agree the timeline with your prescriber while you still use effective contraception.
The gap differs between medicines. Do not apply advice for tirzepatide or a shorter-acting GLP-1 medicine to Wegovy. If you switch treatments while planning a pregnancy, ask for one clear plan covering your last dose, contraception and when you can start trying.
Why the advice is cautious
There is little safety information on semaglutide in human pregnancy, and animal studies have raised concerns. So the advice is to avoid exposure. Nobody can predict from a website what will happen in your pregnancy. Claims the drug is definitely safe are unjustified, and so are claims of certain harm.
Weight-loss goals and pregnancy care goals differ. Once you plan a pregnancy or become pregnant, nutrition, glucose control and maternity care need a joined-up approach. Do not keep taking the medicine against pregnancy advice to reach a target weight first.
If you find out you are pregnant
Contact your GP, maternity service or prescriber promptly. Tell them the date of your last injection, the strength and your estimated pregnancy dates. Stop semaglutide as soon as you know you are pregnant. A clinician will assess the exposure and arrange suitable care or specialist information where needed.
Accidental exposure alone does not prove harm to the baby. Do not base big pregnancy decisions on stories online. Keep your medicine records. Ask your clinician about reporting to a pregnancy registry or the MHRA once you have had clinical advice.
Diabetes and other treatment
If you have diabetes, take extra care with any treatment change. Poorly controlled glucose carries its own pregnancy risks. Do not stop insulin or other needed treatment without advice. Get your diabetes team involved early so you have a pregnancy-safe plan with no gap in glucose control.
Preconception care also covers your other medicines, folic acid and any health conditions. These decisions rest on your full medical history, and Wegovy is one part of the picture. Your prescribing service should share information with the clinicians who will look after your pregnancy and diabetes.
Breastfeeding and restarting later
UK guidance advises against semaglutide while you breastfeed because there is not enough safety information. Talk through feeding plans and treatment priorities with the right clinician. Your recovery after birth, your nutrition and how you feed your baby come before a weight-loss timetable.
Restarting after pregnancy or breastfeeding is a fresh prescribing decision. Do not go back to an old high dose from a part-used pen. Your time off treatment, current health, weight, contraception and how well you tolerated the medicine before all count. Old pens also have expiry dates and storage limits. Make a restart plan with your prescriber once your situation is clear.
Sources
Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.
- Wegovy FlexTouch UK prescribing information medicines.org.uk
- MHRA: GLP-1 medicines, what you need to know gov.uk
Spotted something out of date? Report a mistake.